The Halyard Health, Inc. (HYH) Given Average Recommendation of “Hold” by Brokerages, Report finds

The Halyard Health, Inc. (HYH) Given Average Recommendation of “Hold” by Brokerages, Report finds

Several research firms recently issued reports on HYH. JMP Securities cut Halyard Health from an “outperform” rating to a “market perform” rating and set a $38.00 price target on the stock. in a report on Friday, January 6th. Zacks Investment Research cut Halyard Health from a “buy” rating to a “hold” rating in a report on Thursday, January 5th. Finally, Deutsche Bank AG cut Halyard Health from a “buy” rating to a “hold” rating and set a $35.00 price target on the stock. in a report on Thursday, December 15th.

Halyard Health, Inc. (NYSE:HYH) has been assigned an average recommendation of “Hold” from the six analysts that are currently covering the stock. Four research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $37.00.

Institutional investors have recently added to or reduced their stakes in the stock. JPMorgan Chase & Co. raised its position in Halyard Health by 704.7% in the third quarter. JPMorgan Chase & Co. now owns 608,265 shares of the company’s stock valued at $21,082,000 after buying an additional 532,677 shares during the last quarter. Panagora Asset Management Inc. raised its stake in Halyard Health by 103.2% in the third quarter. Panagora Asset Management Inc. now owns 770,426 shares of the company’s stock worth $26,703,000 after buying an additional 391,232 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in Halyard Health by 17.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,210,051 shares of the company’s stock worth $81,729,000 after buying an additional 330,186 shares in the last quarter. Cove Street Capital LLC raised its stake in Halyard Health by 60.7% in the second quarter. Cove Street Capital LLC now owns 816,808 shares of the company’s stock worth $26,563,000 after buying an additional 308,600 shares in the last quarter. Finally, Hancock Holding Co. acquired a new stake in Halyard Health during the third quarter worth approximately $7,365,000. 87.50% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Halyard Health (NYSE:HYH) opened at 40.14 on Wednesday. The stock has a market cap of $1.87 billion, a price-to-earnings ratio of 42.75 and a beta of 1.87. The stock’s 50 day moving average is $38.24 and its 200-day moving average is $36.15. Halyard Health has a 1-year low of $22.91 and a 1-year high of $40.40.

Halyard Health Company Profile

Halyard Health, Inc seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company operates through two segments: Surgical and Infection Prevention (S&IP) and Medical Devices. Its S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections.

Related posts

Leave a Comment